Sivik Global Healthcare LLC Sarepta Therapeutics, Inc. Transaction History

Sivik Global Healthcare LLC

$185 Million
Q1 2025

A detailed history of Sivik Global Healthcare LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Sivik Global Healthcare LLC holds 20,000 shares of SRPT stock, worth $379,600. This represents 0.69% of its overall portfolio holdings.

Number of Shares

20,000

Previous 10,000 100.0%

Holding current value

$379,600

Previous $1.22 Million 4.93%

% of portfolio

0.69%

Previous 0.64%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	BUY	$104.54 - $137.94 $1.05 Million - $1.38 Million	10,000 New	10,000 $1.22 Million
Q2 2023 Aug 09, 2023	SELL	$106.4 - $157.19 $1.3 Million - $1.92 Million	-12,189 Reduced 93.76%	811 $93,000
Q1 2023 May 05, 2023	BUY	$117.53 - $155.99 $1.53 Million - $2.03 Million	13,000 New	13,000 $1.79 Million
Q1 2022 May 09, 2022	SELL	$63.15 - $90.42 $1.58 Million - $2.26 Million	-25,000 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$77.28 - $99.42 $1.93 Million - $2.49 Million	25,000 New	25,000 $2.25 Million
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $1.65 Million - $2.31 Million	-25,000 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$69.38 - $86.75 $346,900 - $433,750	5,000 Added 25.0%	25,000 $1.94 Million
Q1 2021 May 12, 2021	BUY	$72.25 - $168.95 $1.45 Million - $3.38 Million	20,000 New	20,000 $1.49 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $1.85 Million - $2.96 Million	-22,500 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$76.53 - $135.58 $573,975 - $1.02 Million	7,500 Added 50.0%	22,500 $2.9 Million
Q3 2019 Nov 12, 2019	SELL	$72.81 - $156.91 $910,125 - $1.96 Million	-12,500 Reduced 45.45%	15,000 $1.13 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $1.4 Million - $1.9 Million	12,500 Added 83.33%	27,500 $4.18 Million
Q1 2019 May 08, 2019	SELL	$106.67 - $151.68 $533,350 - $758,400	-5,000 Reduced 25.0%	15,000 $1.79 Million
Q4 2018 Feb 12, 2019	SELL	$97.32 - $148.76 $486,599 - $743,800	-5,000 Reduced 20.0%	20,000 $2.18 Million
Q3 2018 Nov 13, 2018	SELL	$115.31 - $161.51 $576,550 - $807,550	-5,000 Reduced 16.67%	25,000 $4.04 Million
Q4 2017 Feb 08, 2018	BUY	$47.64 - $56.75 $1.43 Million - $1.7 Million	30,000	30,000 $1.67 Million

Others Institutions Holding SRPT

# of Institutions

508

Shares Held

88.9M

Call Options Held

1.39M

Put Options Held

1.13M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.66B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.

Account

Sivik Global Healthcare LLC Sarepta Therapeutics, Inc. Transaction History